行情

BIOL

BIOL

拜拉斯
NASDAQ

实时行情|Nasdaq Last Sale

0.4519
-0.0181
-3.85%
盘后: 0.4502 -0.0017 -0.38% 16:51 11/26 EST
开盘
0.4497
昨收
0.4700
最高
0.4565
最低
0.4300
成交量
248.60万
成交额
--
52周最高
1.510
52周最低
0.2650
市值
6,926.70万
市盈率(TTM)
-3.0679
分时
5日
1月
3月
1年
5年
48 Stocks Moving In Friday's Mid-Day Session
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded higher amid concerns of a new COVID variant discovered in South Africa.
Benzinga · 1天前
25 Stocks Moving in Friday's Pre-Market Session
Gainers
Benzinga · 1天前
Biolase granted extension to regain compliance with Nasdaq's listing rule
Biolase (NASDAQ:BIOL) has been granted a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company now has until May 23, 2022
Seekingalpha · 4天前
BIOLASE Reports Nasdaq Granted Co. 180-Day Extension To Meet Minimum Bid Price Requirement; Enter Favorable Credit Deal
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its receipt of written notification from the Listing Qualification Department of The NASDAQ Stock Market ("Nasdaq") granting
Benzinga · 4天前
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery One-on-One Virtual Investor Conference on Thursday, December 2, 2021.
PR Newswire · 4天前
BIOLASE 8-K Shows Co. To Cancel Is Special Meeting Of Shareholders Scheduled For Friday, Will Withdraw Consideration By Shareholders On Proxy Statement
On November 18, 2021, BIOLASE, Inc. (the “Company”) determined to cancel its special meeting of stockholders that was scheduled for November 19, 2021 and to withdraw from consideration by the
Benzinga · 11/18 21:35
BIOLASE Issues Release Urging Shareholders To Vote FOR Reverse Stock Split
The BIOLASE Special Meeting of Stockholders is Scheduled for This Coming Friday, November 19, 2021 FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental
Benzinga · 11/17 21:21
Biolase Granted U.S. Patent Titled 'Laser control GUI system and method'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6377&f=G&l=50&d=PTXT&p=128&S1=20211116&OS=20211116&RS=20211116
Benzinga · 11/16 14:09
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解BIOL最新的财务预测,通过BIOL每股收益,每股净资产,每股现金流等数据分析拜拉斯近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

25.00%强力推荐
75.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测BIOL价格均价为2.250,最高价位3.000,最低价为2.000。
最高3.000
均价2.250
最低2.000
现价0.4519
EPS
实际EPS
预期EPS
-0.06-0.04-0.03-0.01
Q4 2020
Q1 2021
    0
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 59
机构持股: 2,277.14万
持股比例: 14.86%
总股本: 1.53亿
类型机构数股数
增持
12
219.54万
建仓
11
303.42万
减持
8
31.71万
平仓
6
6.17万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-0.02%
医疗设备和用品
-0.85%
高管信息
Non-Executive Chairman/Independent Director
Jonathan Lord
President/Chief Executive Officer/Director
John Beaver
Director
Kathleen O'Loughlin
Director
Martha Somerman
Director
Carol Summerhays
Independent Director
Michael DiTolla
Independent Director
Richard Lanman
Independent Director
Jess Roper
Independent Director
Garrett Sato
Independent Director
Elaine Wagner
公告日期
每股分红
除权日期
--
Dividend USD 0.01
2005/06/24
--
Dividend USD 0.01
2005/04/21
--
Dividend USD 0.01
2005/02/08
--
Dividend USD 0.01
2004/12/13
--
Dividend USD 0.01
2004/10/08
2004/07/27
Dividend USD 0.01
2004/08/12
BIOL 简况
BIOLASE, Inc(BIOLASE) 为牙科行业提供激光系统。该公司为牙医及其患者开发、制造、营销和销售激光系统。该公司提供两类激光系统产品:水激光(全组织)系统和二极管(软组织)系统。水激光牙科激光系统旗舰产品由Waterlase Express、Waterlase iPlus以及Waterlase MD和MDX组成,它们产生具有特定吸收和组织相互作用特性的电磁能量,专为切割硬组织(如骨骼和牙齿)和软组织(如牙龈和皮肤)的牙科手术而设计,但没有与传统牙科治疗相关的热量、振动、出血或压力。其二极管软组织激光系统包括Epic X、Epic Hygiene、Epic Pro、Epic 10和iLase 二极管激光器,处理软组织、进行疼痛治疗和执行美容手术,如牙齿美白。

微牛提供BIOLASE Inc(NASDAQ-BIOL)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的BIOL股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BIOL股票基本功能。